Companies attending the conference 2008
(90% of the delegates are at CEO, CFO, VP or Investment Manager Level). If you want to receive a copy of the evaluation of the Anglonordic Biotech Conference IV, then please contact daniel.johansson@ezenze.com.
| 2cureX |
| 3H Biomedical |
| 4bio |
| AB Cernelle |
| Abingworth |
| Acure Pharma AB |
| AcureOmics AB |
| Aescap |
| Affitech AS |
| Alice Ventures |
| Alligator Bioscience AB |
| Alta Partners |
| AnaMar AB |
| AnNajah University Faculty of Pharmacy |
| Apitope Technology (Bristol) Ltd. |
| Apposite Capital |
| Astion Pharma A/S |
| AstraZeneca |
| Avecia |
| Balter Medical AS |
| BankInvest Biomedical Venture |
| Bergen Teknologioverfoering AS |
| Bergen Teknologioverføring AS |
| Biofund |
| BioKapital |
| Bionor Immuno AS |
| BioPartner.co.uk |
| Bioscience Managers Ltd |
| Biosergen AS |
| Biotech Sweden |
| Biovitrum AB |
| Bone Medical Ltd. |
| Caliber Synthesis AS |
| Camurus |
| Celentyx |
| Celleron Therapeutics |
| Cellzome |
| Chesyl Pharma Ltd |
| Chroma Therapeutics |
| CMC Biologics |
| Colonix Medical Limited |
| Conformetrix Ltd |
| Cronos Therapeutics |
| Crown Bio Technology Ltd |
| Curidium Medica Plc |
| Cyclacel |
| Danish Embassy |
| Dermagene |
| DiaGenic ASA |
| Domantis |
| Eden Biodesign |
| EiRx Therapeutics plc |
| ENKAM Pharmaceuticals A/S |
| Esperante |
| ETV Capital Ltd |
| European Equity Partners |
| Evolva |
| Evotec |
| Farallone Therapeutics |
| FCMB ApS |
| Ferghana |
| FOCUS Clinical Drug Development GmbH |
| GE Healthcare |
| GENA- Institute of DNA analysis |
| Genetrix Life Sciences AB |
| Genomic Expression ApS |
| Gilde Investment Management |
| Healthcap |
| Inagen |
| Innate Pharmaceuticals |
| Innovator Capital |
| International Business Wales |
| Inventages Venture Capital |
| Invest in Denmark |
| IPC International Plc |
| ISA |
| Isis Innovation |
| Jurilab |
| Karo Bio |
| Kerentech slu |
| Kirkstall Ltd |
| LAB Research |
| Life Sciences Partners |
| Linkmed |
| Lipoxen |
| London Business Angels |
| London Stock Exchange |
| Ludesi |
| MEABCO A/S |
| Medeia Therapeutics |
| Medinnova AS |
| Merck Sharp & Dohme |
| Merck Sharp & Dome |
| Mobidiag Ltd |
| MRC Technology (MRCT) |
| Myotec Therapeutics Ltd |
| Neurokey |
| NGN Capital |
| Nomura Phase4 Ventures |
| Northern Antibiotics Ltd |
| Novaquest |
| NovaThera |
| Novo Seeds |
| Novo Venture |
| NovoSeeds |
| Oestjysk Innovation A/S |
| Onyvax |
| Oslo Cancer Cluster |
| Oxford Genome Sciences (UK) Ltd |
| OxyPharma |
| Palm Research AS |
| PepTcell Limited |
| Per Foss |
| Pfizer |
| Pharmaterials |
| Pharmidex |
| PhaseOneTrials A/S |
| Plasticell Ltd |
| Plastid |
| Plethora Solutions |
| Prattipati Ramakrishna |
| Proxima Concepts Ltd |
| qsense |
| R5 Pharmaceuticals Ltd |
| ReceptIcon ApS |
| Sarsia Venture Management |
| Scandinavian life science venture |
| Scottish Biomedical |
| Scottish Widows Investment Partnership |
| Seed Capital |
| Sentinel Oncology |
| Seventure Partners |
| Sheffield Bioincubator |
| Shire Pharmaceutical |
| Smerud Medical Research International AS |
| Spirogen |
| Sreedhar Akula |
| Sunstone Capital |
| Tatyasaheb Kore Institute of Engineering & Technology |
| Turku Science Park |
| UK Trade & Investment |
| UK Trade & Investment Sweden |
| University of Westminster |
| Wallder Capital Ltd |
| Wellcome Trust |
| Vicore Pharma AB |
| Vironova |
| Vita Nova Ventures AB |
| Vitrolife |
Companies attending the conference 2007
| 3H Biomedical |
| 3i |
| 4bio |
| A+ Science |
| Abingworth Management Ltd |
| ACE Bioscience |
| Actelion Pharmaceuticals |
| AcurePharma AB |
| Advandx |
| Aescap |
| Affitech AS |
| Alta Partners |
| Amgen |
| AnaMar AB |
| Apposite Capital LLP |
| Atlas Venture |
| Avecia |
| Avesthagen (UK) |
| Avexxin AS |
| Axis-Shield |
| Axordia Limited |
| AstraZeneca |
| Bactus AB |
| BankInvest |
| Bergen Teknologioverfoering AS |
| BioFocus DPI, Part of the Galapagos Group |
| BioMonitor ApS |
| Bioscience Managers Limited |
| Bird & Bird |
| Birkeland Innovation |
| Bristol Myers-Squibb |
| Cambridge Antibody Technology |
| Capio Diagnostik |
| Center for Research on Pharmaceuticals |
| Cephalon |
| Chroma Therapeutics Limited |
| Citigate |
| Cobra Bio |
| Coulter Partners |
| Cresset |
| Cronos Therapeutics |
| Curidium Medica plc |
| Cyclacel |
| Danish Trade Council |
| DeltaDot |
| Department of Health |
| DiaGenic ASA |
| Drugmode |
| E. de Rothschild Investment Partners |
| Eden Biodesign |
| Enkam Pharmaceuticals |
| Equinox Pharma |
| European Equity Partners |
| Evotec |
| Ezenze |
| Farallone Therapeutics BV |
| Ferghana Partners |
| Financial Dynamics |
| FOCUS Clinical Drug Development GmbH |
| GENA – Institute for DNA analysis |
| Genetix |
| Giga |
| Gilde Investment Management |
| Global Life Sciences Ventures |
| Halsin Partners |
| HBM Partners AG |
| Health Protection Agency |
| HealthCap/Odlander&Fredrikson&Co AB |
| HUNT - Biosciences |
| Hunter-Fleming Limited |
| Immunobiology |
| Industrifonden |
| InhibOx, Ltd |
| Innovation Norway |
| Innovationskapital |
| Invest in Sweden Agency |
| Investor Growth Capital AB |
| Ipsat Therapies |
| Isis Innovation |
| Ixico |
| Karolinska Fund |
| Kerentech |
| King's College |
| Kings College London |
| Life Sciences Partners |
| Lingvitae Genomics AS |
| London Seed Capital |
| London Stock Exchange |
| Ludesi |
| Lymphatix Ltd |
| Lytix Biopharma AS |
| MABIT-program, NorInnova AS |
| MDY Healthcare plc |
| Medical Prognosis Institute |
| Merchant Venture Investment |
| Merck Sharp & Dome |
| Migasell AB |
| Millimed |
| Millipore Bioscience Division |
| MVM Life Science Partners Ltd. |
| MycoTeQ A/S |
| Nature Publishing Group |
| NeuroNova |
| New Scientist |
| NGN Capital |
| Nordic Vaccine A/S |
| Nova Thera |
| Novartis |
| Novartis Venture Fund |
| Novo Venture |
| NTNU Technology Transfer AS |
| Nuevolution A/S |
| Omega Fund |
| Optinose AS |
| Orla Protein Technologies |
| Osteologix A/S |
| Oxford Biosensors |
| Oxford Genome Sciences |
| Palm Resarch |
| Paramount |
| Pfizer Limited |
| Pharmidex |
| Photocure |
| Pieris AG |
| Plexus Ventures |
| Precisense |
| Procter & Gamble |
| Proteome Sciences plc |
| Quintiles Limited |
| Regenics AS |
| Reneuron |
| Royal Institute of Technology (KTH) |
| Sareum Ltd |
| Sarsia Venture Management |
| Scottish Biomedical |
| Scottish Development International |
| Scottish Widows Investment Partnership |
| Selvaag Venture Capital |
| Seraphim Capital |
| Seymoure Pierce |
| SGAM |
| Silence Therapeutics AG |
| SJ Berwin |
| SLS Ventures |
| Smerud Medical Research Group |
| Spirogen |
| Stricent |
| Swedish Chamber of Commerce for the UK |
| Swedish Trade Council |
| The Wellcome Trust |
| TheRyte Ltd |
| Think London |
| Trade and Investment Department |
| TTO Nord AS |
| TVM Capital |
| Ubichem PLC |
| UCB Group |
| UK Trade & Investment |
| UK Trade & Investment Stockholm |
| UKTI Sector Champion |
| University of Cambridge, Technology Transfer Office |
| University of Westminster |
| Upperton |
| Vækstfonden |
| Windhover Information |
| VINNOVA |
| WOCP |
| Zymetech (Ensímtækni ehf) |